| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? | Clin Colorectal Cancer | 2011 | 1.02 |
| 2 | Gastrointestinal stromal tumors (GISTs) and second malignancies: A novel "sentinel tumor"? A monoinstitutional, STROBE-compliant observational analysis. | Medicine (Baltimore) | 2016 | 0.75 |
| 3 | Unexpected side effect in mCRC: A care-compliant case report of regorafenib-induced hyperammonemic encephalopathy. | Medicine (Baltimore) | 2017 | 0.75 |
| 4 | Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab. | Medicine (Baltimore) | 2016 | 0.75 |